Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 700 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MapLight Therapeutics, Inc.
Market Cap
$395.93M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$406.60M
Net Profit Margin
-13.96%
TTM Avg
-29.79%
3Y Avg
-27.76%
5Y Avg
-25.86%
Market Cap
$404.24M
Net Profit Margin
-57.42%
TTM Avg
-73.98%
3Y Avg
-95.04%
5Y Avg
-95.04%
Market Cap
$387.27M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-102.82%
5Y Avg
-175.43%
Market Cap
$409.58M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$384.21M
Net Profit Margin
-7.41%
TTM Avg
-13.48%
3Y Avg
-12.88%
5Y Avg
-9.86%
Market Cap
$412.14M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.00%
Market Cap
$380.02M
Net Profit Margin
-391.90%
TTM Avg
-78.17%
3Y Avg
-42.66%
5Y Avg
-429.16%
Market Cap
$414.18M
Net Profit Margin
0.00%
TTM Avg
-4061.84%
3Y Avg
-2030.92%
5Y Avg
-1353.95%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $395.93M | 0.00% | 0.00% | 0.00% | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $406.60M | -13.96% | -29.79% | -27.76% | -25.86% |
| Carlsmed, Inc. (CARL)vs › | $404.24M | -57.42% | -73.98% | -95.04% | -95.04% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $387.27M | 0.00% | 0.00% | -102.82% | -175.43% |
| Shoulder Innovations, Inc. (SI)vs › | $409.58M | -58.33% | -67.34% | -66.78% | -66.78% |
| Orthofix Medical Inc. (OFIX)vs › | $384.21M | -7.41% | -13.48% | -12.88% | -9.86% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $412.14M | 0.00% | 0.00% | 0.00% | 2.00% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $380.02M | -391.90% | -78.17% | -42.66% | -429.16% |
| Neurogene Inc. (NGNE)vs › | $414.18M | 0.00% | -4061.84% | -2030.92% | -1353.95% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $415.78M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-03-31 | 0.00% |
